Quantcast
The Future Of Robotics Is Soft And Practically

The Future Of Robotics Is Soft And Practically Indestructible

Eric Hopton for redOrbit.com - Your Universe Online Fire, snow, water - and being crushed by a car - are no problem for a new “bio-inspired” robot. The science of soft robotics has taken a major leap forward with the production of the first...

Latest research Stories

2014-09-19 12:26:38

DUBLIN, Sept. 19, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Feed Testing (Mycotoxin, Pathogen, Nutritional Labeling, Crop Chemicals, Fats & Oils, and Others) Market - Trends & Forecasts To 2019" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 The need for feed testing emerged due to the occurrence of several diseases in animals due to the consumption of contaminated compound feed. Industrialization has also led...

2014-09-18 23:10:54

Clinovo expands its global reach by partnering with Digitaliza TXT, the leading technology provider to expand ClinCapture, the only free validated EDC system in Latin America Sunnyvale, California (PRWEB) September 18, 2014 Silicon-valley Electronic Data Capture (EDC) provider Clinovo joins forces with Digitaliza TXT, the latest addition to Clinovo’s CRO Partnership Program. With this new addition to its Clinical Research Organization (CRO) Program, Clinovo further expands its global...

2014-09-18 23:09:00

Ira Katz brings more than 30 years in pharmaceuticals to the magazine's editorial advisory board. Philadelphia, PA (PRWEB) September 18, 2014 International management consulting firm Insigniam announced that its consultant, Ira Katz, has been named to the editorial advisory board for Applied Clinical Trials. Applied Clinical Trials is a global, peer-reviewed publication with coverage that features the process of managing clinical trials at the intersection where pharmaceutical product...

2014-09-18 23:05:40

MarketOptimizer.org adds “Edema Global Clinical Trials Review, H2, 2014” to its store. This report provides elemental information and data relating to the clinical trials on Edema. Dallas, Texas (PRWEB) September 18, 2014 Clinical trial report, “Edema Global Clinical Trials Review, H2, 2014″ provides data on the Edema clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Edema. It includes an overview of the trial numbers...

2014-09-18 12:30:02

Liz Moench, President & CEO of MediciGroup® Inc., will Chair the Allan Lloyds Patient Recruitment and Retention Summit Asia-Emerging Markets, 2014 PHILADELPHIA and LONDON, Sept. 18, 2014 /PRNewswire/ -- It's a new era for biopharmaceutical companies. Competition for innovation, increasing clinical development costs, new technologies and a necessity to keep up with the fast-changing environment are important factors driving industry change. These factors also influence clinical trials, and...

2014-09-18 12:29:26

PLYMOUTH MEETING, Pa., Sept. 18, 2014 /PRNewswire/ -- ePharmaSolutions, the leading provider of eClinical trial solutions, was recognized as the Disruptive Innovator of the Year at Dpharm 2014 for its ePharmaONE cloud-based eClinical platform. This solution includes an integrated clinical trial portal and electronic trial master file (eTMF), a remote monitoring application, eSource and electronic informed-consent solution, and ePharmaSolutions' ReferralPlus+ patient screening and...

2014-09-18 08:30:24

FDA Removes Clinical Hold on Phase 2 Clinical Trial SAN DIEGO, Sept. 18, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on patient enrollment and dosing of PEGPH20 in SWOG's ongoing Phase 1b/2 clinical trial (S1313). The trial is designed to evaluate Halozyme's investigational drug PEGPH20 (PEGylated Recombinant Human Hyaluronidase) in combination with modified FOLFIRINOX...

2014-09-18 08:29:10

Drug Development Team Now Complete and Fully Focused on Clinical Trial Implementation NEW YORK, Sept. 18, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has appointed Mr. Christopher W. James to the position of Senior Director of Clinical Development. During his extensive career in Clinical Research, Mr. James has established and led successful global...

2014-09-18 08:20:30

PLYMOUTH MEETING, Pa., Sept. 18, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today CEO Dr. J. Joseph Kim will be presenting at two upcoming investor conferences in New York, NY: Biocentury's NewsMakers in the Biotech Industry Conference and Bernstein's Genes as Drugs Event. NewsMakers in the Biotech IndustrySeptember 26, 20142:30 PM ETInvestor Presentation Bernstein's Genes as DrugsOctober 7, 20141:00 PM ETThis presentation will not be webcasted....

2014-09-17 23:13:48

Leading life sciences and healthcare technology consultancy, d-Wise, takes an active leadership role in PhUSE Annual Conference on clinical trial data transparency. Morrisville, NC (PRWEB) September 17, 2014 d-Wise, a global technology consulting company focused on the life sciences and healthcare industries, will be leading four different presentations at the PhUSE 10th anniversary conference, which is focused on clinical trial data transparency. This industry-leading conference will be...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related